Macquarie Group LTD Bluebird Bio, Inc. Transaction History

Macquarie Group LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.94 - $5.23 $3,722 - $6,621	-1,266 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$8.96 - $16.31 $10,295 - $18,740	-1,149 Reduced 47.58%	1,266 $13,000
Q1 2021 May 14, 2021	SELL	$16.59 - $33.89 $11,165 - $22,807	-673 Reduced 21.79%	2,415 $73,000
Q4 2020 Feb 16, 2021	SELL	$27.5 - $37.92 $263,505 - $363,349	-9,582 Reduced 75.63%	3,088 $134,000
Q3 2020 Nov 13, 2020	SELL	$34.44 - $43.75 $12,260 - $15,575	-356 Reduced 2.73%	12,670 $684,000
Q2 2020 Aug 11, 2020	SELL	$27.12 - $45.97 $101,971 - $172,847	-3,760 Reduced 22.4%	13,026 $795,000
Q1 2020 May 15, 2020	BUY	$26.16 - $63.5 $22,026 - $53,467	842 Added 5.28%	16,786 $772,000
Q4 2019 Feb 14, 2020	BUY	$46.96 - $61.67 $100,259 - $131,665	2,135 Added 15.46%	15,944 $1.4 Million
Q3 2019 Nov 14, 2019	BUY	$59.47 - $93.1 $821,221 - $1.29 Million	13,809 New	13,809 $1.27 Million
Q2 2019 Aug 14, 2019	SELL	$75.84 - $105.21 $34,507 - $47,870	-455 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$64.44 - $104.11 $29,320 - $47,370	455 New	455 $72,000
Q1 2018 May 11, 2018	SELL	$105.8 - $150.94 $2.02 Million - $2.88 Million	-19,102 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$81.25 - $130.7 $35,587 - $57,246	438 Added 2.35%	19,102 $3.4 Million
Q3 2017 Nov 08, 2017	BUY	$57.74 - $91.42 $1.08 Million - $1.71 Million	18,664	18,664 $2.56 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $29.3M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.